MEHMET KOCAK, Ph.D.

Associate Professor
Preventive Medicine

Office: 626 DOCTORS OFFICE BUILDING
66 NORTH PAULINE STREET
MEMPHIS TN 381632181
Tel: (901) 448-2937
mkocak1@uthsc.edu
https://academic.uthsc.edu/docs/fac_port_cv/Mehmet_Kocak_CV_2012_04_02.pdf

Education

  • Ph.D., University of Memphis, Applied Statistics
  • M.S., Michigan State University, Applied Statistics
  • B.S., Hacettepe University, Ankara, Turkey, Statistics

My Current Curriculum Vitae

Research Keywords

 clinical trials, cohort studies, univariate and multivariate regression, generalized linear models, mixed models, gene expression data analysis

Research Interest/Specialty

Clinical Trial Design,

Phase-1 and Phase-II trials,

Categorical data analysis,

Survival analysis,

Longitudinal and Repeated-measure data analysis

Univariate and multivariate distribution of p-values,

Gene expression data analysis,

Periodicity testing for gene expression

Meta Analysis

Publications

  1. Maclin-Akinyemi C, Krukowski RA, Kocak M, Talcott GW, Beauvais A, Klesges RC. Motivations for Weight Loss Among Active Duty Military Personnel. Military medicine, 9 (182).
  2. Paladino, A, Anderson, JN, Graff, C, Krukowski, R, Blue, R, Jones, T, Buzaglo, J, Kocak, M, Vidal, G, Graetz, I. A qualitative exploration of race-based differences in social support needs of diverse women with breast cancer on adjuvant therapy. Psychooncology, 2019.
  3. Hu, Z, Tylavsky, FA, Han, JC, Kocak, M, Fowke, JH, Davis, RL, Lewinn, K, Bush, NR, Zhao, Q. Maternal metabolic factors during pregnancy predict early childhood growth trajectories and obesity risk: the CANDLE Study. Int J Obes (Lond), 2019.
  4. Rowe, AS, Hawkins, B, Hamilton, LA, Ferrell, A, Henry, J, Wiseman, BF, Skovran, SA, Mosadegh, MS, Hare, ME, Kocak, M, Tolley, E. Contrast-Induced Nephropathy in Ischemic Stroke Patients Undergoing Computed Tomography Angiography: CINISter Study. J Stroke Cerebrovasc Dis, 2018.
  5. Fahey, MC, Wayne Talcott, G, Cox Bauer, CM, Bursac, Z, Gladney, L, Hare, ME, Harvey, J, Little, M, McCullough, D, Hryshko-Mullen, AS, Klesges, RC, Kocak, M, Waters, TM, Krukowski, RA. Moms fit 2 fight: Rationale, design, and analysis plan of a behavioral weight management intervention for pregnant and postpartum women in the U.S. military. Contemp Clin Trials, 74, 46-54, 2018.
  6. Ramirez, KA, Choudhri, AF, Patel, A, Lenny, NT, Thompson, RE, Berkelhammer Greenberg, L, Clanton Watson, N, Kocak, M, DeVincenzo, JP. Comparing molecular quantification of herpes simplex virus (HSV) in cerebrospinal fluid (CSF) with quantitative structural and functional disease severity in patients with HSV encephalitis (HSVE): Implications for improved therapeutic approaches. J Clin Virol, 107, 29-37, 2018.
  7. Krukowski, RA, Hare, ME, Talcott, GW, Gladney, LA, Johnson, KC, Richey, PA, Kocak, M, Keller, PL, Hryshko-Mullen, A, Klesges, RC. Dissemination of the Look AHEAD Intensive Lifestyle Intervention in the United States Military: A Randomized Controlled Trial. Obesity (Silver Spring), 26 (10), 1558-1565, 2018.
  8. Fahey, MC, Klesges, RC, Kocak, M, Wayne Talcott, G, Krukowski, RA. Changes in the Perceptions of Self-weighing Across Time in a Behavioral Weight Loss Intervention. Obesity (Silver Spring), 26 (10), 1566-1575, 2018.
  9. Fahey, MC, Hare, ME, Talcott, GW, Kocak, M, Hryshko-Mullen, A, Klesges, RC, Krukowski, RA. Characteristics Associated With Participation in a Behavioral Weight Loss Randomized Control Trial in the U.S. Military. Mil Med, 2018.
  10. Vereen, S, Gebretsadik, T, Johnson, N, Hartman, TJ, Veeranki, SP, Piyathilake, C, Mitchel, EF, Kocak, M, Cooper, WO, Dupont, WD, Tylavsky, F, Carroll, KN. Association Between Maternal 2nd Trimester Plasma Folate Levels and Infant Bronchiolitis. Matern Child Health J, 2018.
  11. Meduri, GU, Bridges, L, Siemieniuk, RAC, Kocak, M. An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome. Crit Care Med, 46 (6), 884-891, 2018.
  12. Satapathy, SK, Das, K, Kocak, M, Helmick, RA, Eason, JD, Nair, SP, Vanatta, JM. No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant. Clin Transplant, 32 (5), e13246, 2018.
  13. Kilburn, LB, Kocak, M, Baxter, P, Poussaint, TY, Paulino, AC, McIntyre, C, Lemenuel-Diot, A, Lopez-Diaz, C, Kun, L, Chintagumpala, M, Su, JM, Broniscer, A, Baker, JN, Hwang, EI, Fouladi, M, Boyett, JM, Blaney, SM. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer, 65 (2), 2018.
  14. Kocak M, Krukowski R, Talcott GW. Processing and Cleaning Streaming Data in SAS. PhamaSUG, 2018.
  15. Kocak M, Mozhui K. An Application of The Bayesian Periodicity Test to Identify Diurnal Rhythm Genes in the Brain. IEEE/ACM transactions on computational biology and bioinformatics, 2018.
  16. Vereen, S, Kocak, M, Potukuchi, PK, Hartman, TJ, Tylavsky, F, Carroll, KN. The association of maternal prenatal vitamin D levels and child current wheeze. Ann Allergy Asthma Immunol, 120 (1), 98-99, 2018.
  17. Gururangan, S, Reap, E, Schmittling, R, Kocak, M, Reynolds, R, Grant, G, Onar-Thomas, A, Baxter, P, Pollack, IF, Phillips, P, Boyett, J, Fouladi, M, Mitchell, D. Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11). Cancer Immunol Immunother, 66 (12), 1589-1595, 2017.
  18. Schaapveld-Davis, CM, Negrete, AL, Hudson, JQ, Saikumar, J, Finch, CK, Kocak, M, Hu, P, Van Berkel, MA. End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State. Clin Diabetes, 35 (4), 202-208, 2017.
  19. Kocak M.. Statistical Comparison of Growth Curve Models in First Years of Life in USA and Turkish Pediatric Populations. Ped Health Res., 2 (2), 2017.
  20. Kocak M.. An Empirical Bayesian Approach in Estimating Odds Ratios for Rare or Zero Events. Turkiye Klinikleri Journal of Biostatistics, 1 (9), 2017.
  21. Masters, J, Kocak, M, Waite, A. Risk for microbial keratitis: Comparative metaanalysis of contact lens wearers and post-laser in situ keratomileusis patients. J Cataract Refract Surg, 43 (1), 67-73, 2017.
  22. Nguyen, AKD, Murphy, LE, Kocak, M, Tylavsky, FA, Pagani, LS. Prospective Associations Between Infant Sleep at 12 Months and Autism Spectrum Disorder Screening Scores at 24 Months in a Community-Based Birth Cohort. J Clin Psychiatry, 79 (1), 2016.
  23. Khan, MA, Akbar, A, Baron, TH, Khan, S, Kocak, M, Alastal, Y, Hammad, T, Lee, WM, Sofi, A, Artifon, EL, Nawras, A, Ismail, MK. Endoscopic Ultrasound-Guided Biliary Drainage: A Systematic Review and Meta-Analysis. Dig Dis Sci, 61 (3), 684-703, 2016.
  24. Satapathy, SK, Eason, JD, Nair, S, Dryn, O, Sylvestre, PB, Kocak, M, Vanatta, JM. Recidivism in Liver Transplant Recipients With Alcoholic Liver Disease: Analysis of Demographic, Psychosocial, and Histology Features. Exp Clin Transplant, 13 (5), 430-40, 2015.
  25. Poussaint, TY, Vajapeyam, S, Ricci, KI, Panigrahy, A, Kocak, M, Kun, LE, Boyett, JM, Pollack, IF, Fouladi, M. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol, 2015.
  26. Meduri, GU, Bridges, L, Shih, MC, Marik, PE, Siemieniuk, RA, Kocak, M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med, 2015.
  27. Tylavsky, FA, Kocak, M, Murphy, LE, Graff, JC, Palmer, FB, Völgyi, E, Diaz-Thomas, AM, Ferry, RJ. Gestational Vitamin 25(OH)D Status as a Risk Factor for Receptive Language Development: A 24-Month, Longitudinal, Observational Study. Nutrients, 7 (12), 9918-30, 2015.
  28. Hoffman, LM, Fouladi, M, Olson, J, Daryani, VM, Stewart, CF, Wetmore, C, Kocak, M, Onar-Thomas, A, Wagner, L, Gururangan, S, Packer, RJ, Blaney, SM, Gajjar, A, Kun, LE, Boyett, JM, Gilbertson, RJ. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Childs Nerv Syst, 31 (8), 1283-9, 2015.
  29. AlRuthia, YS, Hong, SH, Graff, C, Kocak, M, Solomon, D, Nolly, R. Exploring the factors that influence medication rating Web sites value to older adults: A cross-sectional study. Geriatr Nurs, 37 (1), 36-43, 2015.
  30. Mulkern, RV, Ricci, KI, Vajapeyam, S, Chenevert, TL, Malyarenko, DI, Kocak, M, Poussaint, TY. Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom. Acad Radiol, 22 (3), 363-9, 2015.
  31. Kilburn, LB, Kocak, M, Decker, RL, Wetmore, C, Chintagumpala, M, Su, J, Goldman, S, Banerjee, A, Gilbertson, R, Fouladi, M, Kun, L, Boyett, JM, Blaney, SM. A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. Neuro Oncol, 17 (2), 303-11, 2015.
  32. Krukowski, RA, Hare, ME, Talcott, GW, Johnson, KC, Richey, PA, Kocak, M, Balderas, J, Colvin, L, Keller, PL, Waters, TM, Klesges, RC. Dissemination of the Look AHEAD intensive lifestyle intervention in the United States Air Force: study rationale, design and methods. Contemp Clin Trials, 40, 232-9, 2015.
  33. Qaddoumi, I, Kocak, M, Pai Panandiker, AS, Armstrong, GT, Wetmore, C, Crawford, JR, Lin, T, Boyett, JM, Kun, LE, Boop, FA, Merchant, TE, Ellison, DW, Gajjar, A, Broniscer, A. Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas. Front Oncol, 4, 67, 2014.
  34. Rabito, FA, Kocak, M, Werthmann, DW, Tylavsky, FA, Palmer, CD, Parsons, PJ. Changes in low levels of lead over the course of pregnancy and the association with birth outcomes. Reprod Toxicol, 50, 138-44, 2014.
  35. Colón-Ramos, U, Racette, SB, Ganiban, J, Nguyen, TG, Kocak, M, Carroll, KN, Völgyi, E, Tylavsky, FA. Association between dietary patterns during pregnancy and birth size measures in a diverse population in Southern US. Nutrients, 7 (2), 1318-32, 2014.
  36. Zukotynski, K, Fahey, F, Kocak, M, Kun, L, Boyett, J, Fouladi, M, Vajapeyam, S, Treves, T, Poussaint, TY. 18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium. J Nucl Med, 55 (9), 1473-80, 2014.
  37. Zhang, Y, Huang, J, Jiao, Y, David, V, Kocak, M, Roan, E, Di'Angelo, D, Lu, L, Hasty, KA, Gu, W. Bone morphology in 46 BXD recombinant inbred strains and femur-tibia correlation. ScientificWorldJournal, 2015, 728278, 2014.
  38. Strother, DR, Lafay-Cousin, L, Boyett, JM, Burger, P, Aronin, P, Constine, L, Duffner, P, Kocak, M, Kun, LE, Horowitz, ME, Gajjar, A. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro Oncol, 16 (3), 457-65, 2014.
  39. Harris, SM, Davis, JC, Snyder, SE, Butch, ER, Vavere, AL, Kocak, M, Shulkin, BL. Evaluation of the biodistribution of 11C-methionine in children and young adults. J Nucl Med, 54 (11), 1902-8, 2013.
  40. Zukotynski, KA, Fahey, FH, Vajapeyam, S, Ng, SS, Kocak, M, Gururangan, S, Kun, LE, Poussaint, TY. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. J Nucl Med, 54 (8), 1237-43, 2013.
  41. Sedlacik, J, Winchell, A, Kocak, M, Loeffler, RB, Broniscer, A, Hillenbrand, CM. MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol, 34 (7), 1450-5, 2013.
  42. Kocak, M, George, EO, Pyne, S, Pounds, S. An empirical Bayes approach for analysis of diverse periodic trends in time-course gene expression data. Bioinformatics, 29 (2), 182-8, 2013.
  43. Blaney, SM, Kocak, M, Gajjar, A, Chintagumpala, M, Merchant, T, Kieran, M, Pollack, IF, Gururangan, S, Geyer, R, Phillips, P, McLendon, RE, Packer, R, Goldman, S, Banerjee, A, Heideman, R, Boyett, JM, Kun, L. Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). J Neurooncol, 2012.
  44. Qaddoumi, I, Sane, M, Li, S, Kocak, M, Pai-Panandiker, A, Harreld, J, Klimo, P, Wright, K, Broniscer, A, Gajjar, A. Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors. Childs Nerv Syst, 28 (7), 1017-24, 2012.
  45. Pui, CH, Pei, D, Pappo, AS, Howard, SC, Cheng, C, Sandlund, JT, Furman, WL, Ribeiro, RC, Spunt, SL, Rubnitz, JE, Jeha, S, Hudson, MM, Kun, LE, Merchant, TE, Kocak, M, Broniscer, A, Metzger, ML, Downing, JR, Leung, W, Evans, WE, Gajjar, A. Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007. J Clin Oncol, 30 (16), 2005-12, 2012.
  46. Godfraind, C, Kaczmarska, JM, Kocak, M, Dalton, J, Wright, KD, Sanford, RA, Boop, FA, Gajjar, A, Merchant, TE, Ellison, DW. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol, 2012.
  47. Jakacki, RI, Burger, PC, Zhou, T, Holmes, EJ, Kocak, M, Onar, A, Goldwein, J, Mehta, M, Packer, RJ, Tarbell, N, Fitz, C, Vezina, G, Hilden, J, Pollack, IF. Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study. Journal of Clinical Oncology, 2012.
  48. Fouladi, M, Stewart, CF, Olson, J, Wagner, LM, Onar-Thomas, A, Kocak, M, Packer, RJ, Goldman, S, Gururangan, S, Gajjar, A, Demuth, T, Kun, LE, Boyett, JM, Gilbertson, RJ. Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Clin Oncol, 29 (26), 3529-34, 2011.
  49. McLendon, RE, Adekunle, A, Rajaram, V, Koçak, M, Blaney, SM. Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study. Arch Pathol Lab Med, 135 (8), 984-93, 2011.
  50. Ellison, DW, Kocak, M, Figarella-Branger, D, Felice, G, Catherine, G, Pietsch, T, Frappaz, D, Massimino, M, Grill, J, Boyett, JM, Grundy, RG. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed, 10, 7, 2011.
  51. Poussaint, TY, Kocak, M, Vajapeyam, S, Packer, RI, Robertson, RL, Geyer, R, Haas-Kogan, D, Pollack, IF, Vezina, G, Zimmerman, R, Cha, S, Patay, Z, Boyett, JM, Kun, LE. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol, 13 (4), 417-27, 2011.
  52. Ellison, DW, Kocak, M, Dalton, J, Megahed, H, Lusher, ME, Ryan, SL, Zhao, W, Nicholson, SL, Taylor, RE, Bailey, S, Clifford, SC. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol, 29 (11), 1400-7, 2011.
  53. Ellison, DW, Dalton, J, Kocak, M, Nicholson, SL, Fraga, C, Neale, G, Kenney, AM, Brat, DJ, Perry, A, Yong, WH, Taylor, RE, Bailey, S, Clifford, SC, Gilbertson, RJ. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol, 121 (3), 381-96, 2011.
  54. Pollack, IF, Stewart, CF, Kocak, M, Poussaint, TY, Broniscer, A, Banerjee, A, Douglas, JG, Kun, LE, Boyett, JM, Geyer, JR. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol, 13 (3), 290-7, 2011.
  55. Haas-Kogan, DA, Banerjee, A, Poussaint, TY, Kocak, M, Prados, MD, Geyer, JR, Fouladi, M, Broniscer, A, Minturn, JE, Pollack, IF, Packer, RJ, Boyett, JM, Kun, LE. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol, 13 (3), 298-306, 2011.
  56. Zukotynski, KA, Fahey, FH, Kocak, M, Alavi, A, Wong, TZ, Treves, ST, Shulkin, BL, Haas-Kogan, DA, Geyer, JR, Vajapeyam, S, Boyett, JM, Kun, LE, Poussaint, TY. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med, 52 (2), 188-95, 2011.
  57. Löbel, U, Sedlacik, J, Reddick, WE, Kocak, M, Ji, Q, Broniscer, A, Hillenbrand, CM, Patay, Z. Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol, 32 (2), 315-22, 2011.
  58. Geyer, JR, Stewart, CF, Kocak, M, Broniscer, A, Phillips, P, Douglas, JG, Blaney, SM, Packer, RJ, Gururangan, S, Banerjee, A, Kieran, MW, Kun, LE, Gilbertson, RJ, Boyett, JM. A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer, 46 (18), 3287-93, 2010.
  59. Löbel, U, Sedlacik, J, Sabin, ND, Kocak, M, Broniscer, A, Hillenbrand, CM, Patay, Z. Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma. Neuroradiology, 52 (12), 1167-77, 2010.
  60. Broniscer, A, Baker, JN, Tagen, M, Onar-Thomas, A, Gilbertson, RJ, Davidoff, AM, Pai Panandiker, AS, Panandiker, AP, Leung, W, Chin, TK, Stewart, CF, Kocak, M, Rowland, C, Merchant, TE, Kaste, SC, Gajjar, A. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol, 28 (31), 4762-8, 2010.
  61. Zhao, W, Boyett, JM, Kocak, M, Ellison, DW, Wu, Y. Maximum likelihood estimation of reviewers' acumen in central review setting: categorical data. Theor Biol Med Model, 8, 3, 2010.
  62. Fahey, FH, Kinahan, PE, Doot, RK, Kocak, M, Thurston, H, Poussaint, TY. Variability in PET quantitation within a multicenter consortium. Med Phys, 37 (7), 3660-6, 2010.
  63. Sedlacik, J, Löbel, U, Kocak, M, Loeffler, RB, Reichenbach, JR, Broniscer, A, Patay, Z, Hillenbrand, CM. Attenuation of cerebral venous contrast in susceptibility-weighted imaging of spontaneously breathing pediatric patients sedated with propofol. AJNR Am J Neuroradiol, 31 (5), 901-6, 2010.
  64. Miller, NG, Reddick, WE, Kocak, M, Glass, JO, Löbel, U, Morris, B, Gajjar, A, Patay, Z. Cerebellocerebral diaschisis is the likely mechanism of postsurgical posterior fossa syndrome in pediatric patients with midline cerebellar tumors. AJNR Am J Neuroradiol, 31 (2), 288-94, 2010.
  65. Mehmet Kocak, Gaolin Zheng, Giri Narasimhan, E. Olusegun George, Saumyadipta Pyne. Differential meta-analysis for testing the relative importance of two competing null hypotheses over multiple experiments. Special Issue on Statistical Genomics in Journal of Indian Society of Agricultural Statistics, 1 (64), 1-10, 2010.
  66. Onar, A, Kocak, M, Boyett, JM. Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor Consortium. J Biopharm Stat, 19 (3), 437-55, 2009.
  67. Broniscer, A, Baker, SJ, Stewart, CF, Merchant, TE, Laningham, FH, Schaiquevich, P, Kocak, M, Morris, EB, Endersby, R, Ellison, DW, Gajjar, A. Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. Clin Cancer Res, 15 (2), 701-7, 2009.
  68. Williams, G, Fahey, FH, Treves, ST, Kocak, M, Pollack, IF, Boyett, JM, Kun, LE, Poussaint, TY. Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging, 35 (9), 1651-8, 2008.
  69. Haas-Kogan, DA, Banerjee, A, Kocak, M, Prados, MD, Geyer, JR, Fouladi, M, McKnight, T, Poussaint, TY, Broniscer, A, Blaney, SM, Boyett, JM, Kun, LE. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol, 10 (3), 341-7, 2008.
  70. Joshi, BH, Puri, RA, Leland, P, Varricchio, F, Gupta, G, Kocak, M, Gilbertson, RJ, Puri, RK, ,. Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Neuro Oncol, 10 (3), 265-74, 2008.
  71. Loyer, P, Trembley, JH, Grenet, JA, Busson, A, Corlu, A, Zhao, W, Kocak, M, Kidd, VJ, Lahti, JM. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. J Biol Chem, 283 (12), 7721-32, 2008.
  72. MacDonald, TJ, Stewart, CF, Kocak, M, Goldman, S, Ellenbogen, RG, Phillips, P, Lafond, D, Poussaint, TY, Kieran, MW, Boyett, JM, Kun, LE. Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. J Clin Oncol, 26 (6), 919-24, 2008.
  73. Gururangan, S, Turner, CD, Stewart, CF, O'Shaughnessy, M, Kocak, M, Poussaint, TY, Phillips, PC, Goldman, S, Packer, R, Pollack, IF, Blaney, SM, Karsten, V, Gerson, SL, Boyett, JM, Friedman, HS, Kun, LE. Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res, 14 (4), 1124-30, 2008.
  74. Sanders, RP, Kocak, M, Burger, PC, Merchant, TE, Gajjar, A, Broniscer, A. High-grade astrocytoma in very young children. Pediatr Blood Cancer, 49 (7), 888-93, 2007.
  75. Broniscer, A, Baker, SJ, West, AN, Fraser, MM, Proko, E, Kocak, M, Dalton, J, Zambetti, GP, Ellison, DW, Kun, LE, Gajjar, A, Gilbertson, RJ, Fuller, CE. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol, 25 (6), 682-9, 2007.
  76. Calabrese, C, Poppleton, H, Kocak, M, Hogg, TL, Fuller, C, Hamner, B, Oh, EY, Gaber, MW, Finklestein, D, Allen, M, Frank, A, Bayazitov, IT, Zakharenko, SS, Gajjar, A, Davidoff, A, Gilbertson, RJ. A perivascular niche for brain tumor stem cells. Cancer Cell, 11 (1), 69-82, 2007.
  77. Broniscer, A, Laningham, FH, Kocak, M, Krasin, MJ, Fouladi, M, Merchant, TE, Kun, LE, Boyett, JM, Gajjar, A. Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer, 106 (6), 1364-71, 2006.
  78. Broniscer, A, Chintagumpala, M, Fouladi, M, Krasin, MJ, Kocak, M, Bowers, DC, Iacono, LC, Merchant, TE, Stewart, CF, Houghton, PJ, Kun, LE, Ledet, D, Gajjar, A. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol, 76 (3), 313-9, 2006.
  79. Fouladi, M, Gilger, E, Kocak, M, Wallace, D, Buchanan, G, Reeves, C, Robbins, N, Merchant, T, Kun, LE, Khan, R, Gajjar, A, Mulhern, R. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol, 23 (28), 7152-60, 2005.
  80. Howard, V, Greene, JM, Pahwa, S, Winkelstein, JA, Boyle, JM, Kocak, M, Conley, ME. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol, 118 (2-3), 201-8, 2005.
  81. Mulhern, RK, Palmer, SL, Merchant, TE, Wallace, D, Kocak, M, Brouwers, P, Krull, K, Chintagumpala, M, Stargatt, R, Ashley, DM, Tyc, VL, Kun, L, Boyett, J, Gajjar, A. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol, 23 (24), 5511-9, 2005.
  82. Fouladi, M, Chintagumpala, M, Laningham, FH, Ashley, D, Kellie, SJ, Langston, JW, McCluggage, CW, Woo, S, Kocak, M, Krull, K, Kun, LE, Mulhern, RK, Gajjar, A. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol, 22 (22), 4551-60, 2004.
  83. Gajjar, A, Hernan, R, Kocak, M, Fuller, C, Lee, Y, McKinnon, PJ, Wallace, D, Lau, C, Chintagumpala, M, Ashley, DM, Kellie, SJ, Kun, L, Gilbertson, RJ. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol, 22 (6), 984-93, 2004.
  84. Gilbertson, RJ, Hill, DA, Hernan, R, Kocak, M, Geyer, R, Olson, J, Gajjar, A, Rush, L, Hamilton, RL, Finkelstein, SD, Pollack, IF. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res, 9 (10 Pt 1), 3620-4, 2003.